MasTec Inc vs Sana Biotechnology Inc — how do they compare? MasTec Inc trades at $350.55 (market cap $26.60B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: MasTec Inc is far larger — about 30.4× Sana Biotechnology Inc's market cap, and MasTec Inc is trading nearer its 52-week high, Sana Biotechnology Inc nearer its low. Which is the better fit depends on your goals.
| MTZ | SANA | |
|---|---|---|
Market Cap | $26.60B | $873.84M |
Sector | Technology | Health |
52-Week High | $437.51 | $5.92 |
52-Week Low | $172.51 | $2.68 |
Enterprise Value | $29.34B | $848.03M |
Trailing returns across standard periods
MasTec, Inc. is a leading infrastructure construction company operating mainly in North America. The company's services cover a diverse range of end-markets, including communications (building fiber and wireless infrastructure), oil & gas, electric power (transmission, distribution, and clean energy), and industrial projects. MTZ provides critical engineering, procurement, and construction (EPC) services that support the expansion and maintenance of essential infrastructure across the continent.
Read more on MTZ →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →